The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Cost-Effectiveness of Psychological and Pharmacological Interventions for Generalized Anxiety Disorder and Panic Disorder
Abstract
Objective: To assess from a health sector perspective the incremental cost-effectiveness of interventions for generalized anxiety disorder (cognitive behavioural therapy [CBT] and serotonin and noradrenaline reuptake inhibitors [SNRIs]) and panic disorder (CBT, selective serotonin reuptake inhibitors [SSRIs] and tricyclic antidepressants [TCAs]). Method: The health benefit is measured as a reduction in disability-adjusted life years (DALYs), based on effect size calculations from meta-analyses of randomised controlled trials. An assessment on second stage filters (‘equity’, ‘strength of evidence’, ‘feasibility’ and ‘acceptability to stakeholders’) is also undertaken to incorporate additional factors that impact on resource allocation decisions. Costs and benefits are calculated for a period of one year for the eligible population (prevalent cases of generalized anxiety disorder/panic disorder identified in the National Survey of Mental Health and Wellbeing, extrapolated to the Australian population in the year 2000 for those aged 18 years and older). Simulation modelling techniques are used to present 95% uncertainty intervals (UI) around the incremental cost-effectiveness ratios (ICERs). Results: Compared to current practice, CBT by a psychologist on a public salary is the most cost-effective intervention for both generalized anxiety disorder (A$6900/DALY saved; 95% UI A$4000 to A$12 000) and panic disorder (A$6800/DALY saved; 95% UI A$2900 to A$15 000). Cognitive behavioural therapy results in a greater total health benefit than the drug interventions for both anxiety disorders, although equity and feasibility concerns for CBT interventions are also greater. Conclusions: Cognitive behavioural therapy is the most effective and cost-effective intervention for generalized anxiety disorder and panic disorder. However, its implementation would require policy change to enable more widespread access to a sufficient number of trained therapists for the treatment of anxiety disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163
Borkovec, T. D., & Costello, E. (1993) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.61.4.611 · Cited by 756
A meta-analysis of treatment outcome for panic disorder
Gould, R. A., Ott, M. W., & Pollack, M. H. (1995) · Clinical Psychology Review · doi:10.1016/0272-7358(95)00048-8 · Cited by 520
Ladouceur, R., Dugas, M. J., Freeston, M. H., Léger, E., Gagnon, F., & Thibodeau, N. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.6.957 · Cited by 446
Butler, G., Fennell, M., Robson, P., & Gelder, M. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.167 · Cited by 365 · cited 2×
“Five small RCTs (total intervention n = 84 participants) met the inclusion criteria for CBT [28–32] and two larger RCTs (total intervention n = 435) met the inclusion criteria for venlafaxine [18,19].”
BackgroundAllgulander, C., Hackett, D., & Salinas, E. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.1.15 · Cited by 175
ISSAKIDIS, C., SANDERSON, K., CORRY, J., ANDREWS, G., & LAPSLEY, H. (2004) · Psychological Medicine · doi:10.1017/s003329170300881x · Cited by 110 · cited 1×
“[37] examines disability averted by providing a mix of ‘optimal therapies’ to those receiving ‘current therapies’ for a mix of anxiety disorders.”
BackgroundSertraline treatment of panic disorder: results of a long-term study
Rapaport, M. H., Wolkow, R., Rubin, A., Hackett, E., Pollack, M., & Ota, K. Y. (2001) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2001.00263.x · Cited by 79
Research works printed but not linked: 35
- 1. Mathers C D, Vos T, Stevenson C. The burden of disease and injury in Australia. Australian Institute of Health and Welfare, Canberra 1999.
- 10.3810/pgm.1999.05.1.740 · doi:10.3810/pgm.1999.05.1.740
- 3. World Health Organisation. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. GenevaSwitzerland 1992.
- 4. Australian Bureau of Statistics. Mental health and wellbeing: profile of adults, Australia 1997. Australian Bureau of Statistics, Canberra 1998.
- 5. Therapeutic Guidelines Limited. Therapeutic guidelines: psychotropic 4th edn. Therapeutic Guidelines Limited, Melbourne 2000.
- 7. Kapczinski F, Schmitt R, Lima M. The use of antidepressants for generalized anxiety disorder. The Cochrane Library,: Issue 2. Update Software, Oxford.
- 8. Sheehan D V. Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data. Journal of Clinical Psychiatry 2001; 62(Suppl. 19)26–31.
- 10.1001/jama.283.23.3082 · DOI · Paper page
- 10.1176/appi.ajp.157.6.968 · DOI · Paper page
- 10.4088/JCP.v62n07a04 · DOI
- 12. Pollack M H Zaninelli R Goddard A. 2001; 62: 350–357. · DOI · Paper page
- 10.1111/j.1600-0447.1997.tb09660.x · DOI · Paper page
- 10.1097/00004714-199804000-00006 · DOI
- 15. Caswell A. MIMS, Caswell A. MediMedia Australia, Sydney 2001.
- 10.1080/j.1440-1614.2003.01254.x · DOI
- 17. Haby M, Carter R, Mihalopoulos C, Magnus A, Andrews G, Vos T. Assessing Cost-Effectiveness –Mental Health: introduction to the study and methods. Australian and New Zealand Journal of Psychiatry 2004; 38: 569–578.
- 10.4088/JCP.v60n0805 · DOI · Paper page
- 20. Australian Bureau of Statistics. Census data 2000: population by age and sex, Australian states and territories. Australian Bureau of Statistics, Canberra 2001, Time series spreadsheet, 32010.0: Table 9.
- 10.1111/j.1600-0447.1991.tb03176.x · DOI · Paper page
- 22. Keller M. The long-term clinical course of generalised anxiety disorder. Journal of Clinical Psychiatry 2002; 63(Suppl. 8)11–16.
- 10.1192/bjp.176.6.544 · DOI · Paper page
- 10.1023/B:QURE.0000037482.92757.82 · DOI
- 27. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV) 4th edn. American Psychiatric Press, Washington, DC 1994.
- 10.1192/bjp.165.3.315 · DOI · Paper page
- 10.1017/S014134730001689X · DOI
- 10.1093/oso/9780192631770.001.0001 · DOI · Paper page
- 35. Palisade Corporation. @RISK [computer program] Risk Analysis Add-in for Microsoft Excel. Palisade Corporation, Newfield, NY 2001, Version 4.
- 10.1037/0022-006X.68.4.556 · doi:10.1037/0022-006x.68.4.556 · Paper page
- 10.1097/00004850-200015020-00006 · DOI
- 10.1192/bjp.174.3.213 · DOI
- 10.1034/j.1600-0447.2001.00263.x · DOI · Paper page
- 10.1111/j.1600-0447.1999.tb05385.x · DOI
- 10.1192/S0007125000293513 · DOI
- 43. Perry S. Combining antidepressants and psychotherapy: rationale and strategies. Journal of Clinical Psychiatry 1990; 51(Suppl.)16–20.
- 10.1176/ajp.147.1.51 · DOI · Paper page
Cited by
McHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A., & Otto, M. W. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07757 · Cited by 800
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
Roy-Byrne, P., Craske, M. G., Sullivan, G., Rose, R. D., Edlund, M. J., Lang, A. J., Bystritsky, A., Welch, S. S., Chavira, D. A., Golinelli, D., et al. (2010) · JAMA · doi:10.1001/jama.2010.608 · Cited by 452
“vantages over pharmacotherapy in terms of maintaining clinical improvements over time.(12,13) In response to primary care clinician preferences for interventions that have the capacity to address a range of common mental disorders rather than just one, we designed a flexible treatment delivery model, Coordinated Anxie…”
MethodHerring, M. P., Jacob, M. L., Suveg, C., Dishman, R. K., & O’Connor, P. J. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000327898 · Cited by 200
Hedman, E., Andersson, E., Ljótsson, B., Andersson, G., Rück, C., & Lindefors, N. (2011) · Behaviour Research and Therapy · doi:10.1016/j.brat.2011.07.009 · Cited by 183
Metadata
- Authors
- Heuzenroeder, L., Donnelly, M., Haby, M. M., Mihalopoulos, C., Rossell, R., Carter, R., Andrews, G., & Vos, T.
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2004-08
- Volume
- 38
- Issue
- 8
- Pages
- 602-612
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W2102630283
- Cited by
- 164
- References
- 8
- FWCI
- 17.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-Effectiveness of Psychological and Pharmacological Interventions for Generalized Anxiety Disorder and Panic Disorder. https://app.cochat.ai/papers/10.1080/j.1440-1614.2004.01423.x
- The paper
- Heuzenroeder, L., Donnelly, M., Haby, M. M., Mihalopoulos, C., Rossell, R., Carter, R., Andrews, G., & Vos, T. (2004). Cost-Effectiveness of Psychological and Pharmacological Interventions for Generalized Anxiety Disorder and Panic Disorder. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1080/j.1440-1614.2004.01423.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.